Naturhouse Health (NTH) | Financial Analysis & Statements
Naturhouse Health S.A.U. | Small-cap | Consumer Defensive
Naturhouse Health S.A.U. | Small-cap | Consumer Defensive
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
49.4M
Gross Profit
35.5M
71.75%
Operating Income
13.1M
26.58%
Net Income
9.9M
19.96%
Balance Sheet Metrics
Total Assets
42.6M
Total Liabilities
10.9M
Shareholders Equity
31.7M
Debt to Equity
0.34
Cash Flow Metrics
Operating Cash Flow
14.2M
Free Cash Flow
11.2M
Revenue & Profitability Trend
Naturhouse Health Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 49.4M | 50.4M | 52.4M | 57.6M | 55.1M |
| Cost of Goods Sold | 14.0M | 13.7M | 14.9M | 16.3M | 15.9M |
| Gross Profit | 35.5M | 36.7M | 37.5M | 41.3M | 39.2M |
| Operating Expenses | 10.1M | 8.7M | 11.4M | 10.6M | 9.6M |
| Operating Income | 13.1M | 16.3M | 12.8M | 17.5M | 14.4M |
| Pre-tax Income | 13.5M | 15.4M | 13.1M | 18.2M | 13.5M |
| Income Tax | 3.7M | 4.2M | 3.5M | 4.9M | 4.1M |
| Net Income | 9.9M | 11.2M | 9.6M | 13.4M | 9.4M |
| EPS (Diluted) | - | €0.19 | €0.16 | €0.22 | €0.16 |
Income Statement Trend
Naturhouse Health Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 28.2M | 34.4M | 27.1M | 37.3M | 33.4M |
| Non-Current Assets | 14.4M | 14.5M | 15.8M | 11.7M | 9.1M |
| Total Assets | 42.6M | 48.8M | 42.8M | 49.0M | 42.6M |
| Liabilities | |||||
| Current Liabilities | 6.5M | 12.8M | 8.4M | 8.1M | 9.7M |
| Non-Current Liabilities | 4.4M | 5.5M | 6.6M | 4.9M | 6.8M |
| Total Liabilities | 10.9M | 18.2M | 15.0M | 12.9M | 16.5M |
| Equity | |||||
| Total Shareholders Equity | 31.7M | 30.6M | 27.9M | 36.1M | 26.0M |
Balance Sheet Composition
Naturhouse Health Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 13.5M | 15.4M | 13.1M | 18.2M | 13.5M |
| Operating Cash Flow | 14.2M | 15.6M | 9.8M | 19.8M | 14.4M |
| Investing Activities | |||||
| Capital Expenditures | 189.0K | 49.0K | 0 | - | - |
| Investing Cash Flow | 1.2M | 111.0K | -4.3M | -4.2M | 132.0K |
| Financing Activities | |||||
| Dividends Paid | -12.0M | -6.0M | -18.0M | -3.6M | - |
| Financing Cash Flow | -16.1M | -7.7M | -18.0M | -6.3M | -3.4M |
| Free Cash Flow | 11.2M | 20.4M | 6.1M | 16.1M | 14.4M |
Cash Flow Trend
Naturhouse Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.03
Forward P/E
8.40
Price to Book
3.34
Price to Sales
2.14
PEG Ratio
8.40
Profitability Ratios
Profit Margin
19.96%
Operating Margin
23.24%
Return on Equity
31.65%
Return on Assets
17.96%
Financial Health
Current Ratio
4.36
Debt to Equity
13.48
Beta
0.57
Per Share Data
EPS (TTM)
€0.16
Book Value per Share
€0.53
Revenue per Share
€0.82
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| nth | 105.8M | 11.03 | 3.34 | 31.65% | 19.96% | 13.48 |
| Airbus SE | 131.2B | 29.70 | 5.96 | 21.07% | 6.33% | 64.60 |
| Aena S.M.E., S.A | 34.2B | 17.25 | 3.97 | 24.69% | 33.55% | 83.40 |
| Ferrovial SE | 31.2B | 9.79 | 5.18 | 49.66% | 35.41% | 142.78 |
| Acciona S.A | 8.0B | 18.91 | 1.66 | 9.28% | 2.02% | 197.49 |
| Merlin Properties | 6.2B | 19.57 | 0.81 | 4.29% | 58.66% | 68.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.